about
M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosisToxin-based therapeutic approachesThe quest for an effective and safe personalized cell therapy using epigenetic toolsLoss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomasMethylation mattersCTCF maintains differential methylation at the Igf2/H19 locusLoss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.Modeling genetic imprinting effects of DNA sequences with multilocus polymorphism data.Modeling the aneuploidy control of cancer.Imprinted genes as potential genetic and epigenetic toxicologic targetsEpigenetics and DNA methylation come of age in toxicology.Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality.Similarities in the Age-Specific Incidence of Colon and Testicular CancersGenomic imprinting and environmental disease susceptibility.Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse StrainsTissue-specific inactivation of murine M6P/IGF2R.Gametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies.Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancerClinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.Small nucleolar RNAs in cancer.Pyrosequencing for the rapid and efficient quantification of allele-specific expressionCellular reprogramming and cancer development.Identification of residues essential for carbohydrate recognition by the insulin-like growth factor II/mannose 6-phosphate receptor.M6P/IGF2R is mutated in squamous cell carcinoma of the lung.HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme.Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.The mannose 6-phosphate/insulin-like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells.Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells.Interview. Epigenomics, imprinting and disease susceptibility.Identification of developmentally regulated mesodermal-specific transcript in mouse embryonic metanephros.Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas.Epigenomics - Impact for Drug Safety Sciences
P2860
Q24805128-C8122A1A-3B5A-4A92-90FA-B3E0BEADE9E5Q27013664-90280A2B-7C64-412B-8383-9D253BF59CCFQ28079389-07D2DDB5-08AE-4BB8-B501-1F1FEFAB4C16Q28181944-900BD3D9-268A-4F54-864D-5589A5666482Q28364163-5A6008BB-3F28-448D-9671-016F25728404Q28593901-D07A7EC2-0FA0-4340-B033-307A873FC6C0Q33227693-D00AF67C-9674-43B1-A392-379D6062A5EAQ33492605-771AEC7B-ADCC-4300-994F-5784B5537826Q33622981-32E76ECB-D4C0-4C7C-A507-56054547A728Q33852775-3C23FADD-A8ED-4E70-B7F7-0B68C4D1CF70Q34124480-8B84B8B3-4EEF-407F-8ED6-1FC1071625D0Q34276391-4A862503-C352-4733-AD6C-DE6F060BFDF4Q34805872-5574C27D-5057-4CA4-8191-7EF955E24AA4Q35135044-5DF32630-B2B4-4F12-A8F5-B4BEF0512E03Q35633879-638A75EC-74BF-48FF-B424-D7834A10E9B0Q35748838-F4339CE3-E494-4F0D-8A44-B2917AF7637FQ36251483-CCC1F056-8395-4594-B2CC-3C4EC64AB516Q36285430-F4BA5A60-B93C-4068-BEB9-39FD47F9BA6EQ37220672-343999F1-F52F-44C3-9FAF-53AAE6FFED97Q37346566-AA5FCD2C-04B2-4028-A6E9-DB305D05EC38Q37478176-D7FA2ADB-8877-4F49-990F-D4CD3052F717Q38062512-7CE1CF34-5859-4B6D-AE33-6309B2DA352FQ38292872-FCB11AE7-8C84-4FC4-BE9B-D166B1C66CC0Q38465535-069C63B1-A344-428E-976B-5F755F261508Q41264327-27A6DF5B-9A54-4253-BF28-E9E0BB82080CQ43663105-04EAE8D8-54A5-401B-BBAE-A6A1556BCC26Q46132552-3E594B21-725D-45E1-BA40-B88143C5CA27Q48042328-A3033554-DE70-4091-B6DF-E4DED660DEBCQ48318057-EDC6C5A1-BA41-4D51-B620-80B163798E27Q52121623-581E8E1C-3ADE-4EF3-B082-CCA22E28432BQ55473382-2F901721-9CE9-4677-994A-07E541ECE25AQ57970772-1E7D5C8A-6D4D-4E46-9C63-CA772DD9260C
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Genomic imprinting and cancer.
@ast
Genomic imprinting and cancer.
@en
Genomic imprinting and cancer.
@nl
type
label
Genomic imprinting and cancer.
@ast
Genomic imprinting and cancer.
@en
Genomic imprinting and cancer.
@nl
prefLabel
Genomic imprinting and cancer.
@ast
Genomic imprinting and cancer.
@en
Genomic imprinting and cancer.
@nl
P356
P1476
Genomic imprinting and cancer.
@en
P2093
P356
10.1006/EXCR.1999.4453
P407
P577
1999-04-01T00:00:00Z